{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T01:41:04Z","timestamp":1758591664516,"version":"3.44.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiolog\u00eda"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.rx.2020.01.001","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T07:50:38Z","timestamp":1582271438000},"page":"365-375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["An\u00e1lisis de los factores radiopatol\u00f3gicos del c\u00e1ncer de mama triple negativo y determinaci\u00f3n de perfiles de riesgo"],"prefix":"10.1016","volume":"62","author":[{"given":"Cristina","family":"Sebasti\u00e1n Sebasti\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Garc\u00eda Mur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bel\u00e9n","family":"Gros Ba\u00f1eres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Cruz Ciria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Santiago","family":"Rosero Cuesta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00e9s","family":"Su\u00f1\u00e9n Amador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.rx.2020.01.001_bib0190","first-page":"569","article-title":"Cancer stem cells biomarkers in triple negative invasive carcinoma of the breast and associated in situ lesions","volume":"55","author":"Comanescu","year":"2014","journal-title":"Rom J Morphol."},{"key":"10.1016\/j.rx.2020.01.001_bib0195","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.clinimag.2017.10.016","article-title":"Magnetic resonance (MR) features in triple negative breast cancer (TNBC) vs receptor positive cancer (nTNBC)","volume":"14","author":"Angelini","year":"2018","journal-title":"Clinical Imaging."},{"key":"10.1016\/j.rx.2020.01.001_bib0200","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10549-016-4059-6","article-title":"Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer","volume":"161","author":"Li","year":"2017","journal-title":"Breast Cancer Res Treat."},{"key":"10.1016\/j.rx.2020.01.001_bib0205","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.breast.2018.04.018","article-title":"MRI and PET\/CT for evaluation of the pathological response to neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis","volume":"40","author":"Li","year":"2018","journal-title":"Breast."},{"key":"10.1016\/j.rx.2020.01.001_bib0210","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10549-014-3170-9","article-title":"Association between rim enhancement of breast cancer on dynamic contrast-enhanced MRI and patient outcome: impact of subtype","volume":"148","author":"Schmitz","year":"2014","journal-title":"Breast Cancer Res Treat."},{"key":"10.1016\/j.rx.2020.01.001_bib0215","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1055\/s-0035-1546050","article-title":"Prognostic factors for local, locoregional and systemic recurrence in early-stage breast cancer","volume":"75","author":"K\u00fcmmel","year":"2015","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"10.1016\/j.rx.2020.01.001_bib0220","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1148\/radiol.2016152331","article-title":"Imaging Features of Triple-Negative Breast Cancer: Association with Response to Neoadjuvant Chemotherapy and Recurrence-Free Survival","volume":"281","author":"Bae","year":"2016","journal-title":"Radiology."},{"key":"10.1016\/j.rx.2020.01.001_bib0225","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.rx.2016.02.004","article-title":"Valoraci\u00f3n de los factores pron\u00f3sticos radiopatol\u00f3gicos del c\u00e1ncer de mama triple negativo y an\u00e1lisis del carcinoma in situ como factor pron\u00f3stico","volume":"58","author":"Sebasti\u00e1n Sebasti\u00e1n","year":"2016","journal-title":"Radiolog\u00eda."},{"key":"10.1016\/j.rx.2020.01.001_bib0230","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1148\/rg.2016150178","article-title":"A Pictorial Review of Changes in the BI-RADS Fifth Edition","volume":"36","author":"Rao","year":"2016","journal-title":"Radiographics."},{"key":"10.1016\/j.rx.2020.01.001_bib0235","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1245\/s10434-011-2200-7","article-title":"Accuracy of predicting axillary lymph node positivity by physical examination, mammography, ultrasonography, and magnetic resonance imaging","volume":"19","author":"Valente","year":"2012","journal-title":"Ann Surg Oncol."},{"key":"10.1016\/j.rx.2020.01.001_bib0240","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1148\/radiol.2252011605","article-title":"Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement","volume":"225","author":"Michel","year":"2002","journal-title":"Radiology."},{"key":"10.1016\/j.rx.2020.01.001_bib0245","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/jmri.21802","article-title":"Magnetic resonance imaging for axillary staging in patients with breast cancer","volume":"30","author":"Mortellaro","year":"2009","journal-title":"J Magn Reson Imaging."},{"unstructured":"Programa Nacional de Consensos Inter-Sociedades. Programa Argentino de Consensos de Enfermedades Oncol\u00f3gicas. Factores pron\u00f3sticos y predictivos en c\u00e1ncer de mama temprano, consenso nacional inter-sociedades. Mayo, 2016. Disponible en: https:\/\/www.revistasamas.org.ar\/revistas\/2016_v36_n128\/4.pdf.","key":"10.1016\/j.rx.2020.01.001_bib0250"},{"key":"10.1016\/j.rx.2020.01.001_bib0255","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.22381","article-title":"Prognostic markers in triple-negative breast cancer","volume":"109","author":"Rakha","year":"2007","journal-title":"Cancer."},{"key":"10.1016\/j.rx.2020.01.001_bib0260","first-page":"2737","article-title":"Prognostic factors in early-stage triple negative breast cancer: Lessons and limits from clinical practice","volume":"33","author":"Pistelli","year":"2013","journal-title":"Anti-cancer Res."},{"key":"10.1016\/j.rx.2020.01.001_bib0265","doi-asserted-by":"crossref","first-page":"99","DOI":"10.5812\/iranjradiol.4876","article-title":"Breast ductal carcinoma in situ: morphologic and kinetic MRI findings","volume":"10","author":"Nadrljanski","year":"2013","journal-title":"Iran J Radiol."},{"key":"10.1016\/j.rx.2020.01.001_bib0270","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1148\/rg.336125055","article-title":"Ductal carcinoma in situ of the breasts: review of MR imaging features","volume":"33","author":"Greenwood","year":"2013","journal-title":"Radiographics."},{"key":"10.1016\/j.rx.2020.01.001_bib0275","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/tbj.12948","article-title":"MR imaging appearance of noncalcified and calcified DCIS","volume":"24","author":"Scott-Moncrieff","year":"2018","journal-title":"Breast J."},{"key":"10.1016\/j.rx.2020.01.001_bib0280","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12282-014-0572-9","article-title":"Focal breast edema associated with malignancy on T2-weighted images of breast MRI: peritumoral edema, prepectoral edema, and subcutaneous edema","volume":"22","author":"Uematsu","year":"2015","journal-title":"Breast Cancer."},{"key":"10.1016\/j.rx.2020.01.001_bib0285","doi-asserted-by":"crossref","first-page":"e7170","DOI":"10.1097\/MD.0000000000007170","article-title":"Role of breast magnetic resonance imaging in predicting malignant invasion of the nipple-areolar complex: Potential predictors and reliability between inter-observers","volume":"96","author":"Liao","year":"2017","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.rx.2020.01.001_bib0290","doi-asserted-by":"crossref","first-page":"9007","DOI":"10.1038\/s41598-018-23999-8","article-title":"The Prognostic Value of Nodal Staging in Triple-Negative Breast Cancer - A Cohort from China","volume":"8","author":"Yin","year":"2018","journal-title":"Sci Rep."},{"key":"10.1016\/j.rx.2020.01.001_bib0295","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/PAI.0b013e31823f4663","article-title":"Predictors of pathologic complete response after standard neoadjuvant chemotherapy in triple-negative breast carcinoma","volume":"20","author":"Kraus","year":"2012","journal-title":"Appl Immunohistochem Mol Morphol."},{"key":"10.1016\/j.rx.2020.01.001_bib0300","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ejca.2003.08.015","article-title":"The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile","volume":"40","author":"Mathieu","year":"2004","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.rx.2020.01.001_bib0305","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1200\/JCO.2005.03.111","article-title":"Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes","volume":"23","author":"Cristofanilli","year":"2005","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.rx.2020.01.001_bib0310","doi-asserted-by":"crossref","first-page":"e0182397","DOI":"10.1371\/journal.pone.0182397","article-title":"Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma","volume":"12","author":"Chen","year":"2017","journal-title":"PLoS One."},{"key":"10.1016\/j.rx.2020.01.001_bib0315","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ejso.2017.11.027","article-title":"Clinicopathologic features and prognoses of different histologic types of triple-negative breast cancer: A large population-based analysis","volume":"44","author":"Zhao","year":"2018","journal-title":"Eur J Surg Oncol."},{"key":"10.1016\/j.rx.2020.01.001_bib0320","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.breast.2015.01.007","article-title":"P53 status identifies triple-negative breast cancer patients who do not respond to adjuvant chemotherapy","volume":"24","author":"Coradini","year":"2015","journal-title":"Breast."},{"key":"10.1016\/j.rx.2020.01.001_bib0325","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10549-018-4928-2","article-title":"Differences in prognosis and efficacy of chemotherapy by p53 expression in triple-negative breast cancer","volume":"172","author":"Bae","year":"2018","journal-title":"Breast Cancer Res Treat."},{"key":"10.1016\/j.rx.2020.01.001_bib0330","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.3892\/or.2017.5553","article-title":"Overexpression of p53 protein is a marker of poor prognosis in Mexican women with breast cancer","volume":"37","author":"Dimas-Gonz\u00e1lez","year":"2017","journal-title":"Oncol Rep May."},{"key":"10.1016\/j.rx.2020.01.001_bib0335","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1309\/AJCP9DV3EVZUATFV","volume":"135","author":"Han","year":"2011","journal-title":"Am J Clin Pathol."},{"key":"10.1016\/j.rx.2020.01.001_bib0340","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc2693","article-title":"When mutations gain new powers: news from the mutant p53 field","volume":"9","author":"Brosh","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.rx.2020.01.001_bib0345","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1038\/sj.onc.1210302","article-title":"TP53 mutations in human cancers: functional selection and impacton cancer prognosis and outcomes","volume":"26","author":"Peitjean","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.rx.2020.01.001_bib0350","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10549-018-4753-7","article-title":"Mutant p53 in breast cancer: potential as a therapeutic target and biomarker","volume":"170","author":"Duffy","year":"2018","journal-title":"Breast cancer Res Treat."},{"key":"10.1016\/j.rx.2020.01.001_bib0355","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3727\/096504016X14562725373879","article-title":"Neoadjuvant chemotherapy in triple negative breast cancer: An observational study","volume":"23","author":"Shao","year":"2016","journal-title":"Oncol Res."},{"key":"10.1016\/j.rx.2020.01.001_bib0360","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/path.4691","article-title":"Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutations","volume":"238","author":"Guerini-Rocco","year":"2016","journal-title":"J Pathol."},{"key":"10.1016\/j.rx.2020.01.001_bib0365","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1200\/JCO.2011.38.8595","article-title":"Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes","volume":"30","author":"Von Minckwitz","year":"2012","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.rx.2020.01.001_bib0370","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1245\/s10434-015-4921-5","article-title":"Locorregional control according to breast cancer subtype and response to neodyuvant chemotherapy in breast cancer patients undergoing breast-conserving therapy","volume":"23","author":"Swisher","year":"2016","journal-title":"Ann Surg Oncol."}],"container-title":["Radiolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033833820300096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033833820300096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:45:29Z","timestamp":1758501929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033833820300096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0033833820300096"],"URL":"https:\/\/doi.org\/10.1016\/j.rx.2020.01.001","relation":{},"ISSN":["0033-8338"],"issn-type":[{"type":"print","value":"0033-8338"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An\u00e1lisis de los factores radiopatol\u00f3gicos del c\u00e1ncer de mama triple negativo y determinaci\u00f3n de perfiles de riesgo","name":"articletitle","label":"Article Title"},{"value":"Radiolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rx.2020.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 SERAM. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}